# OXALIPLATIN
> **NDA022160** · New Drug Application · Sponsor: TEVA PHARMS · Approved 2009-08-07
## Drug
- **FDA Application Number:** NDA022160
- **Application type:** New Drug Application
- **Brand name:** OXALIPLATIN
- **Generic name:** Oxaliplatin
- **Active ingredients:** OXALIPLATIN
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** TEVA PHARMS
- **First approval:** 2009-08-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022160)
---
*AI Analytics · CC0 1.0*